Physician profile

Jeffrey Abend

Orthopaedic Surgery · Silver Spring, MD

NPI 1073555777

$640.61

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$38.32

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $206.94 2019-2021
Horizon Therapeutics Plc $108.25 2019-2020
Zimmer Biomet Holdings, INC. $82.66 2019-2020
Ferring Pharmaceuticals INC. $61.43 2021-2022
Pacira Therapeutics, INC. $50.30 2019
Fidia Pharma USA INC. $32.89 2021-2023 Hymovis, Triluron
Heraeus Medical, LLC. $24.95 2021
Bioventus LLC $22.87 2021
Sanofi-Aventis U.S. LLC $20.37 2023
Ermi LLC $19.05 2020
Electronic Waveform Lab, INC. $10.90 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeffrey Abend

$640.61

in general payments reported 2019-2025

Years
2019-2023
Top company
Stryker Corporation

https://glasscript.com/doctor/507716/jeffrey-abend

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.